UnitedHealth (UNH) Director Receives 261 Deferred Stock Units on 10/01/2025

John H. Noseworthy, a director of UnitedHealth Group Inc. (UNH), reported acquisition of 261 deferred stock units on 10/01/2025 as part of regular quarterly director compensation.

Rhea-AI Filing Summary

John H. Noseworthy, a director of UnitedHealth Group Inc. (UNH), reported acquisition of 261 deferred stock units on 10/01/2025 as part of regular quarterly director compensation. The units were granted at $0 (deferred awards) and are immediately vested but must be held until the director leaves the Board. After the transaction, Dr. Noseworthy beneficially owns 6,693 shares (direct). The Form 4 was signed by attorney-in-fact Faraz A. Choudhry on 10/03/2025. The filing indicates this is a single reporting person filing and identifies the reporter as a Director of the issuer.

Positive

• 261 deferred stock units granted as regular director compensation, aligning interests with shareholders
• Deferred units are immediately vested, showing no service-based vesting delay
• Post-transaction beneficial ownership of 6,693 shares increases director stake

Negative

• None.

Insights

Corporate Governance Analyst

Director received routine deferred stock units totaling 261 on 10/01/2025.

The transaction reflects standard director compensation: 261 deferred stock units granted as quarterly compensation and recorded at $0 because they are deferred, vested awards. The requirement that units be retained until board service ends aligns with common retention policies.

This is a procedural, non-cash grant that increases the director's beneficial ownership to 6,693 shares, which slightly raises alignment between the director and shareholders.

Insider Trade Summary

Grant/Award: 261 shares

Grant/Award 1 txn

Insider Noseworthy John H

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Common Stock	261	$0.00	$0.00

Holdings After Transaction: Common Stock — 6,693 shares (Direct)

Footnotes (1)

1. F1. Represents deferred stock units that are granted as regular quarterly compensation for service as a director of UnitedHealth Group. Deferred stock units are immediately vested, but must be retained by the director until the director's completion of service on the Board.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What did UnitedHealth director John H. Noseworthy report on Form 4 (UNH)?

He reported acquisition of 261 deferred stock units on 10/01/2025 granted as regular quarterly director compensation.

How many shares does John H. Noseworthy beneficially own after the reported transaction?

Following the transaction he beneficially owns 6,693 shares (direct).

Were the deferred stock units vested or subject to future vesting conditions?

The deferred stock units are stated as immediately vested but must be retained until the director completes service on the Board.

What price was reported for the deferred stock units on the Form 4?

The units were reported at a price of $0, consistent with deferred non-cash awards.

Who signed the Form 4 for John H. Noseworthy and when?

The Form 4 was signed by attorney-in-fact Faraz A. Choudhry on 10/03/2025.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 10/03/2025 - 04:19 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

1. Name and Address of Reporting Person^*

Noseworthy John H

(Last) (First) (Middle)

C/O UNITEDHEALTH GROUP INCORPORATED

1 HEALTH DRIVE

(Street)

EDEN PRAIRIE MN 55344

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
UNITEDHEALTH GROUP INC [ UNH ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
10/01/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	10/01/2025		A		261(1)	A	$0	6,693	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Represents deferred stock units that are granted as regular quarterly compensation for service as a director of UnitedHealth Group. Deferred stock units are immediately vested, but must be retained by the director until the director's completion of service on the Board.

Remarks:

	Faraz A. Choudhry, Attorney-in-Fact for John H. Noseworthy M.D.	10/03/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.